Bank of New Hampshire Sells 4,042 Shares of Cardinal Health, Inc. $CAH

Bank of New Hampshire decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 16.8% in the 2nd quarter, Holdings Channel reports. The fund owned 20,008 shares of the company’s stock after selling 4,042 shares during the period. Bank of New Hampshire’s holdings in Cardinal Health were worth $3,361,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Nomura Holdings Inc. lifted its stake in Cardinal Health by 138.7% in the 4th quarter. Nomura Holdings Inc. now owns 9,783 shares of the company’s stock valued at $1,157,000 after purchasing an additional 5,684 shares during the last quarter. Rafferty Asset Management LLC grew its stake in shares of Cardinal Health by 11.0% during the fourth quarter. Rafferty Asset Management LLC now owns 27,444 shares of the company’s stock worth $3,246,000 after buying an additional 2,711 shares during the last quarter. Royal Bank of Canada increased its holdings in shares of Cardinal Health by 1.4% during the fourth quarter. Royal Bank of Canada now owns 744,599 shares of the company’s stock worth $88,064,000 after buying an additional 10,315 shares in the last quarter. Toronto Dominion Bank lifted its stake in shares of Cardinal Health by 10.2% in the 4th quarter. Toronto Dominion Bank now owns 132,697 shares of the company’s stock valued at $15,694,000 after acquiring an additional 12,236 shares during the last quarter. Finally, Tidal Investments LLC grew its position in Cardinal Health by 23.9% during the 4th quarter. Tidal Investments LLC now owns 20,105 shares of the company’s stock worth $2,369,000 after acquiring an additional 3,882 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

CAH stock opened at $150.45 on Tuesday. The stock’s 50 day simple moving average is $154.16 and its 200 day simple moving average is $148.08. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44. The company has a market cap of $35.93 billion, a P/E ratio of 23.33, a price-to-earnings-growth ratio of 1.29 and a beta of 0.73.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the prior year, the business earned $1.84 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is currently 31.63%.

Insider Buying and Selling

In related news, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the sale, the chief executive officer owned 200,000 shares in the company, valued at $30,008,000. This represents a 15.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 over the last ninety days. Insiders own 0.09% of the company’s stock.

Analysts Set New Price Targets

CAH has been the subject of a number of recent research reports. Argus set a $189.00 target price on Cardinal Health in a report on Friday, August 22nd. Robert W. Baird upped their price objective on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Leerink Partners dropped their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an “outperform” rating for the company in a report on Tuesday, August 12th. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $185.00 price target (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.